118 related articles for article (PubMed ID: 37042960)
1. In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoids.
Amin FG; Elfiky AA; Nassar AM
J Biomol Struct Dyn; 2024; 42(2):1079-1087. PubMed ID: 37042960
[TBL] [Abstract][Full Text] [Related]
2. Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective.
Elshemey WM; Elfiky AA; Ibrahim IM; Elgohary AM
Comput Biol Med; 2022 Jun; 145():105478. PubMed ID: 35421790
[TBL] [Abstract][Full Text] [Related]
3. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.
Fernandez RA; Quimque MT; Notarte KI; Manzano JA; Pilapil DY; de Leon VN; San Jose JJ; Villalobos O; Muralidharan NH; Gromiha MM; Brogi S; Macabeo APG
J Biomol Struct Dyn; 2022; 40(22):12209-12220. PubMed ID: 34463219
[TBL] [Abstract][Full Text] [Related]
4. Chaga Medicinal Mushroom Inonotus obliquus (Agaricomycetes) Terpenoids May Interfere with SARS-CoV-2 Spike Protein Recognition of the Host Cell: A Molecular Docking Study.
Basal WT; Elfiky A; Eid J
Int J Med Mushrooms; 2021; 23(3):1-14. PubMed ID: 33822495
[TBL] [Abstract][Full Text] [Related]
5. Targeting SARS-CoV-2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound.
Eid JI; Das B; Al-Tuwaijri MM; Basal WT
Food Sci Nutr; 2021 Dec; 9(12):6513-6523. PubMed ID: 34900242
[TBL] [Abstract][Full Text] [Related]
6. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the mechanism of interaction of SARS-CoV-2 B.1.640.2 variant RBD with the host receptors hACE2 and GRP78.
Shafiq A; Khalid U; Abdur Rehman U; Abdullah Almuqri E; Muddassir M; Ahmad S; Khan MI; Khan A; Wei DQ
J Biomol Struct Dyn; 2024; 42(4):2034-2042. PubMed ID: 37286365
[TBL] [Abstract][Full Text] [Related]
8. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.
Ibrahim IM; Elfiky AA; Elgohary AM
Biochem Biophys Res Commun; 2021 Jul; 562():89-93. PubMed ID: 34049205
[TBL] [Abstract][Full Text] [Related]
9. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
[TBL] [Abstract][Full Text] [Related]
10. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
[TBL] [Abstract][Full Text] [Related]
11. Oxalic acid blocked the binding of spike protein from SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants to human angiotensin-converting enzymes 2.
Wang M; Yan H; Chen L; Wang Y; Li L; Zhang H; Miao L
PLoS One; 2023; 18(5):e0285722. PubMed ID: 37200310
[TBL] [Abstract][Full Text] [Related]
12.
Pandey AK; Verma S
Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
[TBL] [Abstract][Full Text] [Related]
13. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
Ebrahimi M; Karami L; Alijanianzadeh M
Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
[TBL] [Abstract][Full Text] [Related]
14. Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.
Lazou M; Hutton JR; Chakravarty A; Joseph-McCarthy D
J Comput Aided Mol Des; 2024 Jan; 38(1):6. PubMed ID: 38263499
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective.
Elfiky AA; Ibrahim IM; Elgohary AM
Int J Pept Res Ther; 2022; 28(5):146. PubMed ID: 36034049
[TBL] [Abstract][Full Text] [Related]
16. Effect of Cysteine Oxidation in SARS-CoV-2 Receptor-Binding Domain on Its Interaction with Two Cell Receptors: Insights from Atomistic Simulations.
Ghasemitarei M; Privat-Maldonado A; Yusupov M; Rahnama S; Bogaerts A; Ejtehadi MR
J Chem Inf Model; 2022 Jan; 62(1):129-141. PubMed ID: 34965734
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern.
Chinnadurai RK; Ponne S; Chitra L; Kumar R; Thayumanavan P; Subramanian B
Mol Divers; 2023 Dec; 27(6):2741-2766. PubMed ID: 36547813
[TBL] [Abstract][Full Text] [Related]
18. Accelerating the discovery of the beyond rule of five compounds that have high affinities toward SARS-CoV-2 spike RBD.
Abu-Saleh AAA; Yadav A; Poirier RA
J Biomol Struct Dyn; 2023 Apr; 41(6):2518-2527. PubMed ID: 35132950
[TBL] [Abstract][Full Text] [Related]
19. The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study.
Aksenova AY; Likhachev IV; Grishin SY; Galzitskaya OV
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362302
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Spike Protein-Derived Cyclic Peptides as Modulators of Spike Interaction with GRP78.
Johnson N; Pattinson C; Burgoyne K; Hijazi K; Houssen WE; Milne BF
Chembiochem; 2024 Jun; 25(12):e202300789. PubMed ID: 38613462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
